Feedback / Questions
ATI-052 - Aclaris
https://www.marketbeat.com/instant-alerts/aclaris-therapeutics-touts-ati-052-potential-for-3-month-dosing-more-phase-1-data-incoming-2026-04-14/
Apr 14, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next